Article Text
Therapeutics
Systematic review and meta-analysis
Some oral antidiabetic medications may prevent Type 2 diabetes in people at high risk for it, but the evidence is insufficient to determine whether the potential benefits outweigh the possible risks
Statistics from Altmetric.com
Footnotes
-
Competing interests AJK has received professional consultancy fees, grant funding and/or fees for consultancies and lectures from Astra Zeneca, Bayer, Bristol-Myers Squibb, Eli Lilly, NovoNordisk, Pfizer, Servier and Takeda.